Thank you, Madam Chair.
Good morning to all the witnesses. I thank them for their presentations and for their time.
I would like to put my first question to Ms. Silverman.
You mentioned the idea of temporarily lifting patents on vaccines. That is an idea that we are hearing about more and more. I understand the principle and am even relatively favourable to it. Yet, it might make less of a difference than we think, since the problem seems to be a lack of factories, technology, and labour to make vaccines.
How would a patent waiver fill these gaps?